- Developed by physicians
- Granted U.S. Patent NO.6,491,954
- A randomized, doubleblind, placebo-clinical study published in a leading medical journal found SnoreStop to be effective for over 79% of the treatment group. *
- Four national surveys ranked SnoreStop the #1 recommended brand of anti-snoring products by pharmacists. **
|
|
-
Dual therapeutic action that shrinks swollen soft tissues in the throat where 90% of non-apneic snoring symptoms occur, and it dries built-up mucous in the sinus passages.***
-
No side effects
-
No rebound effects
-
Non-drowsy
-
No drug interaction
-
Non-habit forming
-
No contraindications
-
Not intended for people with sleep apnea
|
